科室与专家门诊
妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握数几十种专业技能，齐心协力，确保高品质治疗与成功康复。
研究
Mayo Clinic is advancing research in retroperitoneal sarcoma through multidisciplinary efforts that combine surgical oncology, translational science and precision medicine. Faculty members are investigating the molecular characteristics of retroperitoneal sarcomas using next-generation sequencing technologies to better understand why these tumors recur after surgical removal and to identify potential new therapeutic targets. This research aims to develop more personalized treatment approaches by integrating genomic information from both the tumor and its microenvironment.
In addition, Mayo Clinic also conducts clinical and translational research focused on sarcoma surgery and treatment sequencing, evaluating strategies that improve outcomes and reduce complications for patients undergoing complex sarcoma resections. Together, these efforts reflect Mayo Clinic's commitment to improving the diagnosis, surgical management and long-term outcomes of patients with retroperitoneal sarcoma through innovative research and multidisciplinary care.
Cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Publications
See a list of publications about retroperitoneal sarcoma by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.